bmiMD vs Novi: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated August 14, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Visit bmiMD - our pick of these two →or find your match

bmiMD beats Novi overall, scoring 8/10 vs 7.8/10. Published pricing is not a like-for-like monthly comparison: bmiMD is $289/mo month-to-month; Novi is from $133/mo. Choose bmiMD for users who want an established, large-scale platform with sam. Choose Novi for cash-pay patients who want compounded semaglutide or tirzepa.

A side-by-side look at bmiMD and Novi to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Higher Rated

bmiMD

#4 of 54

8/10

Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.

Visit bmiMD

Novi

#9 of 54

7.8/10

Telehealth platform for compounded semaglutide and tirzepatide with month-to-month billing, six named clinicians on staff, and a 3-minute pre-approval quiz. Novi emphasizes 'all-in transparent' pricing, medication, supplies, unlimited clinician check-ins, dose adjustments, and weight-loss coaching are bundled with no add-on fees. Standard pricing is $174/mo semaglutide and $283/mo tirzepatide; promotional pricing on the offer landing drops to $99-$133/mo semaglutide and $149-$166/mo tirzepatide with $200 off advertised.

Visit Novi

Feature	bmiMD	Novi
Why each one	One of the largest GLP-1 telehealth platforms (80,000+ customers) with same-day physician consults and a money-back eligibility guarantee.	Combination of six named clinicians (most compounded-only platforms disclose zero or one), month-to-month billing with no commitment, and aggressive promotional pricing as low as $99/mo on the offer landing, a flexibility-and-headcount profile most direct competitors at this price tier do not match.
Our Score	8/10	7.8/10
Headline Price	$289/mo month-to-month	from $133/mo
Medication Type	Both	Compounded
Insurance Accepted	No	No
Best For	Users who want an established, large-scale platform with same-day consults and strong promo pricing	Cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer
Watch out for	Standard semaglutide pricing is $289/mo, above competitors at $99-199/mo; the TAKEOFF 3-month entry (about $99/mo first month) and annual plans from $99/mo bring the effective rate down	Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
Ranking	#4	#9
Get started	Visit bmiMD	Visit Novi

Pros & Cons Compared

bmiMD

Pros

+Same-day physician consults, one of the few platforms offering telehealth appointments the same day you apply
+80,000+ customer base with a 4.3-star Trustpilot rating (600+ reviews) provides real social proof of reliability
+100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
+HSA/FSA accepted for all programs

Cons

−Standard semaglutide pricing is $289/mo, above competitors at $99-199/mo; the TAKEOFF 3-month entry (about $99/mo first month) and annual plans from $99/mo bring the effective rate down
−$29.99 shipping fee per order where most competitors ship free; factor it into your monthly total
−A $50 non-refundable cancellation fee applies after intake approval; decide before the consult, and cancel at least 48 hours ahead of your monthly processing date

Novi

Pros

+Six disclosed clinicians on staff, Daniel Funsch MD, Michael Wasef MD, Takashi Nakamura MD plus three nurse practitioners (Hastings NP, Clements NP, Vergara DNP), more named providers than most compounded-only platforms publish
+Month-to-month billing with no minimum commitment, cancel before any renewal date with no early-termination penalty
+Aggressive promotional pricing on the offer landing, $99-$133/mo compounded semaglutide and $149-$166/mo compounded tirzepatide with a $200 OFF intro discount
+Unlimited clinician check-ins, dose adjustments, and weight-loss coaching included at no additional cost
+Free 2-day shipping; Novi markets compounded semaglutide and tirzepatide, which are not FDA-approved brands or generics and are not established as equivalent to Wegovy, Ozempic, Mounjaro, or Zepbound
+100,000+ patients claimed and editorial coverage in Bloomberg, Forbes, and WebMD provide third-party signal

Cons

−Compounded-only, no FDA-approved Wegovy, Zepbound, Ozempic, or Mounjaro through the platform; no Foundayo or oral GLP-1 formats
−Founding year, headquarters city, and corporate ownership are not publicly disclosed
−Promotional $99-$133 pricing applies to the introductory offer landing only, standard rate after any qualifying intro period is $174-$283/mo (verify the renewal rate before enrolling)
−Once medication is dispensed/shipped, prescriptions cannot be returned or refunded, typical for compounded telehealth but worth understanding
−Lab requirements before prescribing are not disclosed on public pages, unclear whether baseline bloodwork is required
−Multiple landing pages (offer-v4, offer-v6-low) show different headline prices, which can create pricing confusion before checkout

Our Verdict

bmiMD edges out Novi with a score of 8/10 vs 7.8/10. Published pricing is not a like-for-like monthly comparison: bmiMD is $289/mo month-to-month; Novi is from $133/mo. bmiMD offers both brand-name and compounded medications, giving you more flexibility. Choose bmiMD if you want: users who want an established, large-scale platform with same-day consults and strong promo pricing. Choose Novi if you want: cash-pay patients who want compounded semaglutide or tirzepatide on a no-commitment plan with named clinicians, unlimited check-ins, and aggressive promotional pricing as low as $99-$133/mo on the introductory offer.